常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
7.42/13.76
|
|
企业价值
15.75B
|
| 资产负债 |
|
每股账面净值
122.25
|
| 现金流量 |
|
现金流量率
0.09
|
| 损益表 |
|
收益
1.76B
|
|
每股收益
104.98
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2025/11/08 12:23 EST
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. |

159.14 
